• Sonuç bulunamadı

Amplatzer occluder device use for the treatment of ascending aortic pseudoaneurysms

N/A
N/A
Protected

Academic year: 2021

Share "Amplatzer occluder device use for the treatment of ascending aortic pseudoaneurysms"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Turkish Journal of Vascular Surgery 2020;29(1):74 DOI: 10.9739/tjvs.2020.491

www.turkishjournalofvascularsurgery.org

Letter to the Editor

Amplatzer occluder device use for the treatment of ascending aortic pseudoaneurysms

Mustafa Özer Ulukan, Korhan Erkanlı, Murat Uğurlucan

Received: June 10, 2019 Accepted: October 15, 2019 Published online: January 10, 2020

Correspondence: Mustafa Özer Ulukan, MD. Medipol Mega Üniversite Hastanesi, Kalp ve Damar Cerrahisi Bölümü, 34214 Bağcılar, İstanbul, Türkiye.

e-mail: ozerulukan@hotmail.com

Department of Cardiovascular Surgery, Istanbul Medipol University Medical Faculty, Istanbul, Turkey

Citation:

Ulukan MÖ, Erkanlı K, Uğurlucan M. Amplatzer occluder device use for the treatment of ascending aortic pseudoaneurysms. Turk J Vasc Surg 2020;29(1):74 ©2020 Turkish National Vascular and Endovascular Surgery Society. All rights reserved.

We read with interest the manuscript of Megaly et al.[1] in which the authors presented a challenging

treatment of an ascending aortic pseudoaneurysm with endovascular stent grafting. However, we would like to comment on the paper with an alternative treatment option.

With the introduction of advanced technology, medicine and experiences, new devices have been developed for the facilitated treatment for different medical problems in recent years. Occluder devices are one of the pioneers in the field which provide percutaneous treatment of patent ductus arteriosus and atrial septal defects; otherwise, these patients would require open surgical reconstruction. On the other hand, these medical devices are frequently used out of the supplier’s instructions for use. Recently, we implanted an Amplatzer duct occluder II successfully for the treatment of an aortic pseudoaneurysm which developed within six years at the proximal anastomosis region in a patient who underwent supracoronary ascending aortic replacement for the treatment of aortic dissection developed four years after coronary artery bypass grafting.[2]

Considering the presented case of the aforementioned authors, there should be a proximal saphenous vein anastomosis at the ascending aorta.[1] However, it is not clear in the images where

the pseudoaneurysm developed.[1] On the other hand,

theoretically there are two options; i.e. either at the ascending aorta cannulation part or from the proximal saphenous vein anastomosis region. Hence, a long shaft stent graft body may compromise the saphenous vein and coronary flow. Rather, could the authors comment if it could not be possible to implant a smaller Amplatzer occluder device to treat the pathology?

REFERENCES

1. Megaly M, Sharma G, Gudura T, Jones P. Percutaneous thoracic endovascular aortic repair of an ascending aortic pseudoaneurysm: A case report. Turk J Vasc Surg 2019;28:113-6.

2. Yalçın AA, Kahraman S, Yıldırım A, Erkanlı K. An uncommon percutaneous treatment of aortic pseudoaneurysm. Anatol J Cardiol 2018;20:132-3.

Referanslar

Benzer Belgeler

We describe the use of an Amplatzer duct occluder device with the guidance of 3- dimensional transesophageal echocar- diography (3DTEE) in a patient with severe aortic

A-B - Aortic root angiogram in antero-posterior position showing the proximal (A) and distal (B) part of a large tortuous coronary fistula origi- nating from the right coronary

Surgical repair may be performed through two different incisions by thoracotomy and sternotomy in cases treated with surgery in one stage (4) or coarctation treatment may

To rule out the etiology of AI, TEE was performed and revealed LV dilatation with mildly thickened aortic cusp edges, moderate to severe AI and muscu- lar chordae originating from

In conclusion, this study showed that in myocardial injury in the experimental infrarenal aortic ischemia- reperfusion model, the tissue superoxide dismutase and

Transcatheter closure of large pulmonary arteriovenous fistula including pulmonary artery to left atrial fistula with Amplatzer septal occluder. Transcatheter closure of

Aortic banding has also been reportedly used for the surgical treatment of a refractory type 1 endoleak and also for the preparation of the landing zone prior to thoracic

Primary transcatheter closure of post-MI VSDs may be an alternative to surgery for patients with suitable anatomy of the defect, [2,7-9] and the Amplatzer